Indian J Pharm Close
 

Figure 2: Progression-free survival (PFS) (a) and median overall survival (OS) (b) of 23 malignant pleural mesothelioma patients. (a) The median PFS was 7.0 months, (b) the median OS was 13.5 months

Figure 2: Progression-free survival (PFS) (a) and median overall survival (OS) (b) of 23 malignant pleural mesothelioma patients. (a) The median PFS was 7.0 months, (b) the median OS was 13.5 months